-adrenoceptor-selective partial agonist (pA2
values are 7.4 - 7.8 and 5.2 - 6.2 at β1
- and β2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of AstraZeneca UK Ltd.
β-Adrenoceptor stimulant properties of aminoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols.
Barlow et al.
The in vitro pharmacology of xamoterol (ICI 118,587).
Malta et al.
The cardiovascular effects of ICI 118,587: a β1-adrenoceptor partial agonist.
Nuttall and Snow
The citations listed below are publications that use Tocris products. Selected citations for Xamoterol hemifumarate include:
Showing Results 1 - 7 of 7